Brind.

Mesoblast is part of the Australian Biotechs industry.

1 report, 1 independent Updated Aug 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Mesoblast

Keep exploring

The entities involved

Mesoblast
pharmaceutical company
- Trump pledged to unleash American oil and gas production.Sun 15:33
- Mesoblast is seeking FDA review of the BLA for its product rexlemestrocel-L.Thu 12:51

Related events

State Street Corporation accumulated a 5.1% stake in Mesoblast, with shares trading on the Australian Securities Exchange.Aug 17

Coverage

Newest first; wire copies grouped

Aug 30Simply Wall St.Mesoblast Full Year 2025 Earnings: Misses Expectations Revenue: US$17.2m (up 191% from FY 2024). Net loss: US$102.1m (loss widened by 16% from FY 2024). US$0.085 loss per share. Trump has pledged to